Alzheon Garners $4,294,629 New Round

  • Feed Type
  • Date
    2/26/2015
  • Company Name
    Alzheon
  • Mailing Address
    111 Speen Street Framingham, MA 01701 USA
  • Company Description
    Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders.
  • Website
    http://www.alzheon.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,294,629
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing – amended. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor